Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institutes of Health
Sign in and complete your Funding Passport to see whether you qualify — a transparent, rule-based verdict, not a black box.
Sign InAbout this opportunity
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Required documents
The official source lists no specific documents here — confirm requirements before applying.
Source & verification trail
- Official source
- Grants.gov — U.S. General Services Administration ↗
- First retrieved
- July 17, 2026
- Last verified
- July 20, 2026
- Content fingerprint
89db086c9214048b…